Bruhn Suzanne Louise has filed 27 insider transactions across 4 companies since June 2023.
Most recent transaction: a disposition of 24073 shares of Vigil Neuroscience, Inc. ($VIGL) on August 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | D | Stock Option Award (Right to Buy) | 24073 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.05% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | D | Stock Option Award (Right to Buy) | 33875 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.07% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | D | Stock Option Award (Right to Buy) | 13928 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.03% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | D | Common Stock | 5000 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.01% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | D | Stock Option Award (Right to Buy) | 18068 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.04% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | D | Stock Option Award (Right to Buy) | 6235 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.01% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | D | Stock Option Award (Right to Buy) | 24310 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.05% |
| June 12, 2025 | Definium Therapeutics, Inc. | $DFTX | Bruhn Suzanne Louise | Not found | A | Stock Option (Right to Buy) | 75187 | $0.00 | 75,187.0000 | 75,368,359 | 9999.99% | 0.10% |
| June 5, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Bruhn Suzanne Louise | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| May 22, 2025 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | A | Common Stock | 5000 | $0.00 | 5,000.0000 | 46,671,534 | 9999.99% | 0.01% |
| May 15, 2025 | Travere Therapeutics, Inc. | $TVTX | Bruhn Suzanne Louise | Not found | A | Common Stock | 6500 | $0.00 | 28,750.0000 | 78,888,861 | 29.21% | 0.01% |
| May 15, 2025 | Travere Therapeutics, Inc. | $TVTX | Bruhn Suzanne Louise | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| March 3, 2025 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | A | Stock Option Award (Right to Buy) | 33875 | $0.00 | 33,875.0000 | 46,671,534 | 9999.99% | 0.07% |
| June 13, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Bruhn Suzanne Louise | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2024 | Definium Therapeutics, Inc. | $DFTX | Bruhn Suzanne Louise | Not found | A | Stock Option (Right to Buy) | 16506 | $0.00 | 16,506.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | A | Stock Option Award (Right to Buy) | 18068 | $0.00 | 18,068.0000 | 0 | 9999.99% | 0.00% |
| May 8, 2024 | Travere Therapeutics, Inc. | $TVTX | Bruhn Suzanne Louise | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | Travere Therapeutics, Inc. | $TVTX | Bruhn Suzanne Louise | Not found | A | Common Stock | 6500 | $0.00 | 22,250.0000 | 74,267,418 | 41.27% | 0.01% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | A | Stock Option Award (Right to Buy) | 24310 | $0.00 | 24,310.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | D | Stock Option Award (Right to Buy) | 24310 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | D | Stock Option Award (Right to Buy) | 6235 | $7.62 | 0.0000 | 0 | 100.00% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | A | Stock Option Award (Right to Buy) | 6235 | $0.00 | 6,235.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | D | Stock Option Award (Right to Buy) | 13928 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | A | Stock Option Award (Right to Buy) | 13928 | $0.00 | 13,928.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Vigil Neuroscience, Inc. | $VIGL | Bruhn Suzanne Louise | Not found | A | Stock Option Grant (Right to Buy) | 24073 | $0.00 | 24,073.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2023 | Definium Therapeutics, Inc. | $DFTX | Bruhn Suzanne Louise | Director | A | Common Shares | 13671 | $0.00 | 19,623.0000 | 0 | 229.69% | 0.00% |
| June 21, 2023 | Definium Therapeutics, Inc. | $DFTX | Bruhn Suzanne Louise | Director | A | Stock Option (Right to Buy) | 19203 | $0.00 | 27,267.0000 | 0 | 238.13% | 0.00% |